ATN International, Inc. updated its 2026 guidance (reaffirmed).
“Adjusted EBITDA 2 is expected to be in the range of $190 million to $200 million, excluding the impacts from the pending US tower portfolio sale 4 that was recently announced”
Quarterly and annual results disclosed under 8-K Item 2.02.
ATN International, Inc. updated its 2026 guidance (reaffirmed).
“Adjusted EBITDA 2 is expected to be in the range of $190 million to $200 million, excluding the impacts from the pending US tower portfolio sale 4 that was recently announced”
ATN International, Inc. reported financial results for three and twelve months ended December 31, 2025.
“On March 4, 2026, ATN International, Inc. (the “Company”) issued a press release announcing financial results for the three and twelve months ended December 31, 2025.”
ACORN ENERGY, INC. reported fourth quarter (Q4'25) and full-year ended December 31, 2025 results: revenue $ 2,377 $ 3,529 -32.6 % $ 11,478 $ 10,986 +4.5%, net income $ 1,074 $ 5,233 -79.5 % $ 2,510 $ 6,294 -60.1 %, EPS $ 0.42 $ 2.08 $ -1.66 $ 0.99 $ 2.51 $ -1.52.
“Q4’24 Change 2025 2024 Change Monitoring revenue $ 1,411 $ 1,203 +17.3% $ 5,560 $ 4,553 +22.1% Hardware revenue $ 966 $ 2,326 -58.5 % $ 5,918 $ 6,433 -8.0 % Total revenue (1) $ 2,377 $ 3,529 -32.6 % $ 11,478 $ 10,986 +4.5% Gross margin 80.1 % 72.4 % +770bps 76.8 % 72.8 % +400bps Net income to stockholders (2) $ 1,074 $ 5,233 -79.5 % $ 2,510 $ 6,294 -60.1 %”
FULL HOUSE RESORTS INC reported the fourth quarter and year ended December 31, 2025 results: revenue $75.4 million, net income $(12.4) million, or $(0.34) per diluted common share.
“(Nasdaq: FLL) today announced results for the fourth quarter and year ended December 31, 2025. On a consolidated basis, revenues in the fourth quarter of 2025 rose 3.4% to $75.4 million, reflecting strong growth at American Place Casino and the continuing ramp-up of operations at Chamonix Casino Hotel, partially offset by the sale of Stockman’s Casino in April”
COSTCO WHOLESALE CORP /NEW reported first 24 weeks of fiscal 2026 ended February 15, 2026 results: revenue Net sales for the first 24 weeks increased 8.7 percent, to $134.22 billion, net income Net income for the first 24 weeks was $4.04 billion, EPS $9.08 per diluted share.
“Net sales for the first 24 weeks increased 8.7 percent, to $134.22 billion, from $123.52 billion last year.”
COSTCO WHOLESALE CORP /NEW reported second quarter (twelve weeks) ended February 15, 2026 results: revenue Net sales for the quarter increased 9.1 percent, to $68.24 billion, net income Net income for the quarter was $2,035 million, EPS $4.58 per diluted share.
“Net sales for the quarter increased 9.1 percent, to $68.24 billion, from $62.53 billion last year.”
Clarus Corp reported the fourth quarter and full year ended December 31, 2025 results: revenue $65.4 million, net income Net loss of $31.3 million, or $(0.81) per diluted share.
“Fourth Quarter 2025 Financial Summary vs. Same Year - Ago Quarter · Sales of $65.4 million compared to $71.4 million. · Gross margin was 27.7% compared to 33.4%; adjusted gross margin of 33.6% compared to 38.0%. · Net loss of $31.3 million, or $(0.81) per diluted share”
CIENA CORP reported fiscal first quarter 2026 results: revenue $1.43 billion, net income $1.03 GAAP and $1.35 adjusted (non-GAAP), EPS $1.03 GAAP and $1.35 adjusted (non-GAAP). Guidance raised.
“Ciena Reports Fiscal First Quarter 2026 Financial Results Summary • Fiscal first quarter 2026 revenue was $1.43 billion, up 33% year-over-year • Fiscal first quarter 2026 adjusted Earnings Per Share (EPS) was $1.35, an increase of 111% compared to fiscal first quarter 2025 • Providing revenue guidance of $1.5 billion plus or minus $50 million for fiscal second quarter 2026 • Raising revenue guidance range for fiscal year 2026 to $5.9 billion to $6.3 billion, a 28% increase year-over-year at the midpoint”
COMPX INTERNATIONAL INC reported year ended December 31, 2025 results: revenue $158.3 million, net income $19.5 million, or $1.58 per basic and diluted common share.
“Net sales for the year ended December 31, 2025 were $158.3 million compared to $145.9 million in the previous year. Operating income was $22.6 million for the year ended December 31, 2025 compared to $17.0 million in 2024. Net income for the year ended December 31, 2025 was $19.5 million, or $1.58 per basic and diluted common share, compared to $16.6 million, or $1.35 per basic and diluted common share, for the same period in 2024.”
COMPX INTERNATIONAL INC reported fourth quarter of 2025 results: revenue $37.7 million, net income $4.7 million, or $.38 per basic and diluted common share.
“CompX International Inc. (NYSE American: CIX) announced today net sales of $37.7 million for the fourth quarter of 2025 compared to $38.4 million in the same period of 2024. Operating income was $5.6 million in the fourth quarter of 2025 compared to $4.9 million in the same period of 2024. Net income was $4.7 million, or $.38 per basic and diluted common share, for the fourth quarter of 2025 compared to $4.5 million, or $.37 per basic and diluted common share, in the same period of 2024.”
CRACKER BARREL OLD COUNTRY STORE, INC reported second quarter of fiscal 2026 ended January 30, 2026 results: revenue $874.8 million, net income $1.3 million, EPS $0.06.
“to improve financial performance and remain confident that we are well-positioned to regain prior momentum.” Second Quarter Fiscal 2026 Highlights · Total revenue was $874.8 million. Compared to the prior year quarter, total revenue decreased 7.9%. o Compared to the prior year quarter, comparable store restaurant sales decreased 7.1% and comparable”
CROSS COUNTRY HEALTHCARE INC reported fourth quarter and full year ended December 31, 2025 results: revenue $236,761, net income $(82,929), EPS $(2.56).
“INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761 (24) % (5) % $ 1,054,293 (22) % Gross profit margin* 20.3 % 30 bps (10) bps 20.3 % (10) bps Net loss attributable to common stockholders $ (82,929) (2,110) % (1,637) % $ (94,852)”
GRAN TIERRA ENERGY INC. reported financial results for the year ended December 31, 2025.
“Gran Tierra Energy Inc. issued a press release announcing its financial and operating results for the year-end December 31, 2025.”
Cellectar Biosciences, Inc. reported the year ended December 31, 2025 results: net income $21.8 million, EPS $8.35 per basic and diluted share.
“Net loss for the full year ending December 31, 2025, was $21.8 million or $8.35 per basic and diluted share”
EyePoint, Inc. reported the fourth quarter and full-year ended December 31, 2025 results: revenue $0.6 million.
“million in October 2025. Exhibit 99.1 Review of Results for the Fourth Quarter Ended December 31, 2025 For the fourth quarter ended December 31, 2025, total net revenue was $0.6 million compared to $11.6 million for the quarter ended December 31, 2024. Net product revenue for the fourth quarter was $0.3 million, compared to net product revenue for the”
Omega Flex, Inc. reported twelve and three months ended December 31, 2025 results: revenue $ 98,296,000, net income $ 14,827,000, EPS $ 1.47.
““Omega Flex, Inc. Announces Fourth Quarter 2025 Earnings” OMEGA FLEX, INC. (OFLX) Twelve Months Ended December 31, Three Months Ended December 31, 2025 2024 2025 2024 Net Sales $ 98,296,000 $ 101,681,000 $ 25,207,000 $ 26,965,000 Net Income attributable to Omega Flex, Inc. $ 14,827,000 $ 18,014,000 $ 3,415,000 $ 4,682,000 Earnings Per Share – Basic and Diluted $ 1.47”
MAGNACHIP SEMICONDUCTOR Corp reported financial results for fourth quarter and full year ended December 31, 2025.
“Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Magnachip Semiconductor Corporation and its consolidated subsidiaries for the fourth quarter and full year ended December 31, 2025, as presented in a press release dated March 4, 2026.”
OOMA INC reported fiscal year ended January 31, 2026 results: revenue $273.6 million, net income $6.5 million, or $0.23 per diluted share.
“: Adjusted EBITDA was $11.5 million, compared to $6.9 million in the fourth quarter of fiscal 2025. Full Year Fiscal 2026 Financial Highlights: • Revenue : Total revenue was $273.6 million, up 7% year-over-year. Subscription and services revenue increased to $252.0 million from $238.6 million in fiscal 2025, and was 92% of total revenue, primarily driven by the”
OOMA INC reported fiscal fourth quarter ended January 31, 2026 results: revenue $74.6 million, net income $4.0 million, or $0.14 per diluted share.
“today released financial results for the fiscal fourth quarter and year ended January 31, 2026. Fourth Quarter Fiscal 2026 Financial Highlights: • Revenue : Total revenue was $74.6 million, up 15% year-over-year. Subscription and services revenue increased to $68.7 million from $60.6 million in the fourth quarter of fiscal 2025, and was 92% of total revenue,”
ACRES Commercial Realty Corp. reported the quarter ended December 31, 2025 results: net income $3.0 million, EPS $(0.43) per share-diluted.
“ACR’s GAAP net loss allocable to common shares was $3.0 million or $(0.43) per share-diluted, for the quarter ended December 31, 2025.”
StubHub Holdings, Inc. updated its Full year 2026 guidance (initiated).
“The Company is providing full year 2026 guidance. The Company expects 2026 GMS of $9.9 billion to $10.1 billion and 2026 Adjusted EBITDA 2 of $400 million to $420 million.”
StubHub Holdings, Inc. reported Fourth quarter ended December 31, 2025 results: revenue $449 million, net income Net loss of $535 million.
“• Revenue of $449 million equal to 19% of GMS. • Net loss of $535 million inclusive of $479 million of non-recurring, non-cash valuation allowance expense.”
StubHub Holdings, Inc. reported Full year ended December 31, 2025 results: revenue $1.7 billion, net income Net loss of $1.9 billion.
“Revenue of $1.7 billion, equal to 19% of GMS.”
StubHub Holdings, Inc. reported quarter and full year ended December 31, 2025 results: revenue $449 million, net income Net loss of $535 million.
“2025 Highlights • Gross Merchandise Sales (“GMS”) 1 of $2.3 billion, with underlying growth of 6% excluding the prior-year impact of the Taylor Swift’s “Eras” Tour. • Revenue of $449 million equal to 19% of GMS. • Net loss of $535 million inclusive of $479 million of non-recurring, non-cash valuation allowance expense. • Adjusted EBITDA 1 of $63 million, representing”
Ocugen, Inc. reported financial results for the fourth quarter and the fiscal year ended December 31, 2025.
“On March 4, 2026, Ocugen, Inc. (the “Company”) issued a press release announcing certain financial results for the fourth quarter and the fiscal year ended December 31, 2025.”
Niagen Bioscience, Inc. reported financial results for the fourth quarter and the year ended December 31, 2025.
“On March 4, 2026, Niagen Bioscience, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and the year ended December 31, 2025.”
VEEVA SYSTEMS INC reported Fiscal year ended January 31, 2026 results: revenue Total revenues for the fiscal year ended January 31, 2026 were $3,195.3 million.
“Total revenues for the fiscal year ended January 31, 2026 were $3,195.3 million, up from $2,746.6 million one year ago, an increase of 16% year over year.”
VEEVA SYSTEMS INC reported Q4 FY2026 (three months ended January 31, 2026) results: revenue Total revenues for the fourth quarter were $836.0 million, net income Fourth quarter net income was $244.2 million, EPS fully diluted net income per share was $1.45.
“Total revenues for the fourth quarter were $836.0 million, up from $720.9 million one year ago, an increase of 16% year over year.”
DUOS TECHNOLOGIES GROUP, INC. reported the year ended December 31, 2025 results: revenue $ 28,156,000, net income $ (9,508,000 ), EPS $ (0.62 ).
“select financial results as of and for the year ended December 31, 2025. Consolidated Statement of Operations (unaudited) For the Year Ended December 31, 2025 Total Revenues $ 28,156,000 Total Cost of Revenues (20,242,000 ) Gross Margin 7,914,000 Total Operating Expenses (17,350,000 ) Loss from Operations (9,436,000 ) Total Other Expense, net (72,000 ) Net Loss $”
Aquestive Therapeutics, Inc. reported financial results for the quarter and fiscal year ended December 31, 2025.
“On March 4, 2026, Aquestive Therapeutics, Inc. issued a press release announcing its reported financial results for the quarter and fiscal year ended December 31, 2025 and providing an update on recent developments in its business.”
Orion Group Holdings Inc updated its the fourth quarter and full year ended December 31, 2025 guidance (initiated).
“On March 3, 2026, Orion Group Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025.”
Global Water Resources, Inc. reported year ended December 31, 2025 results: revenue Total revenue increased 5.8% year-over-year to $55.8 million., net income Net income decreased to $3.0 million or $0.11 per share, a decrease of $2.8 million or 48.9% YoY., EPS $0.11 per share.
“The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Financial Highlights • Total revenue increased 5.8% year-over-year (“YoY”) to $55.8 million. The increase was primarily due to the recent acquisition of seven water systems from Tucson Water, organic connection growth, increased”
Mistras Group, Inc. reported year ended December 31, 2025 results: revenue $724.0 million, net income $16.8 million, EPS $0.53 per diluted share.
“Revenue of $724.0 million, a slight increase after giving effect to the exclusion of voluntary Laboratory consolidations of $7.0 million • Gross profit of $204.5 million, with a gross margin of 28.2%, an expansion of 190 basis points • Net income of $16.8 million and Earnings Per Diluted Share of $0.53 • Record Adjusted EBITDA of $91.1 million, an increase of 10.5%, with an Adjusted EBITDA margin of 12.6%, up 130 basis points”
Mistras Group, Inc. reported fourth quarter ended December 31, 2025 results: revenue $181.5 million, net income $3.9 million, EPS $0.12 per diluted share.
“Revenue of $181.5 million, an increase of 5.1%, with growth across all segments • Gross profit of $51.5 million , reflecting a gross margin of 28.4%, an expansion of 190 basis points • Net income of $3.9 million and Earnings Per Diluted Share of $0.12 • Record Adjusted EBITDA of $24.8 million, an increase of 18.2%, with an Adjusted EBITDA margin of 13.7%, up 160 basis points”
EVERSPIN TECHNOLOGIES INC. reported the fourth quarter and full year ended December 31, 2025 results: revenue $14.8 million, net income $1.2 million, EPS $0.05 per diluted share. Guidance reaffirmed.
“we had 238 design wins, up from 178 in the prior year. These design wins are expected to ramp to production in 2026 and 2027.” Fourth Quarter 2025 Results • Total revenue of $14.8 million, compared to $13.2 million in the fourth quarter of 2024. • MRAM product sales, which include both Toggle and STT-MRAM revenue, of $13.5 million, compared to $11.0 million in the”
ALTISOURCE PORTFOLIO SOLUTIONS S.A. updated its the quarter ended December 31, 2025 and full year 2025 guidance (reaffirmed).
“On March 4, 2026 , Altisource Portfolio Solutions S.A. (“Altisource”) issued a press release announcing its financial results for the quarter ended December 31, 2025 and full year 2025.”
BROWN FORMAN CORP reported nine months ended January 31, 2026 results: revenue $3.0 billion, EPS $1.41. Guidance reaffirmed.
“For the nine months of the fiscal year, the company’s reported net sales decreased 2% to $3.0 billion (flat on an organic basis) compared to the same prior-year period. Year-to-date reported operating income was flat at $905 million (-3% on an organic basis) and diluted earnings per share decreased 8% to $1.41.”
BROWN FORMAN CORP reported third quarter ended January 31, 2026 results: revenue $1.1 billion, EPS $0.58. Guidance reaffirmed.
“Third quarter reported net sales increased 2% 1 to $1.1 billion (+1% on an organic basis 2 ) compared to the same prior-year period. In the quarter, reported operating income increased 21% to $340 million (flat on an organic basis) and diluted earnings per share increased 1% to $0.58.”
Sight Sciences, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue $20.4 million, net income $4.2 million, EPS $0.08 per share. Guidance initiated.
“quarter and full year ended December 31, 2025 and initiated financial guidance for full year 2026. Recent Financial Highlights • Generated fourth quarter 2025 total revenue of $20.4 million, an increase of 7% compared to the same period in the prior year, and full year 2025 total revenue of $77.4 million, a decrease of 3% compared to full year 2024. • Achieved total”
Ellington Credit Co reported the quarter ended December 31, 2025 results: net income $(21.1) million or $(0.56) per share, EPS $(0.56) per share.
“GAAP net income (loss) was $(21.1) million or $(0.56) per share.”
TriplePoint Venture Growth BDC Corp. reported fiscal year ended December 31, 2025 results: revenue $90.9 million, EPS $1.22 per share.
“income of $42.3 million, or $1.05 per share; ▪ Grew the total investment portfolio by $107.3 million ending the year at $783.5 million; ▪ Generated total investment income of $90.9 million; ▪ Paid regular quarterly distributions of $1.06 per share and a supplemental distribution of $0.02 per share; ▪ Signed $1.2 billion of term sheets with venture growth stage”
TriplePoint Venture Growth BDC Corp. reported quarter ended December 31, 2025 results: net income $9.9 million, EPS $0.25 per share.
“Earned net investment income of $9.9 million, or $0.25 per share”
Babcock & Wilcox Enterprises, Inc. reported financial results for the fourth quarter and full year ended December 31, 2025.
“On March 4, 2026, the Company issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2025.”
Okta, Inc. reported fiscal quarter and year ended January 31, 2026 results: revenue $761 million, net income $63 million, EPS $0.35.
“private sector the flexibility to innovate with confidence in the early stages of this new era.” Fourth Quarter Fiscal 2026 Financial Highlights: • Revenue: Total revenue was $761 million , an increase of 11% year-over-year. Subscription revenue was $747 million, an increase of 11% year-over-year. • RPO: RPO, or subscription backlog, was $4.827 billion, an”
Keros Therapeutics, Inc. reported the year ended December 31, 2025 results: net income net income of $87.0 million.
“Keros reported a net loss of $23.5 million for the fourth quarter and net income of $87.0 million for the year ended December 31, 2025”
Keros Therapeutics, Inc. reported the fourth quarter ended December 31, 2025 results: net income net loss of $23.5 million.
“Keros reported a net loss of $23.5 million for the fourth quarter”
Cardlytics, Inc. reported financial results for the fourth quarter ended December 31, 2025.
“On March 4, 2026, the Company issued a press release announcing its financial results for the quarter and year ended December 31, 2025”
NCS Multistage Holdings, Inc. reported the year ended December 31, 2025 results: revenue $183.6 million, net income $23.7 million, EPS $8.65 per diluted share.
“Total revenues of $183.6 million, a 13% improvement over 2024 ● Operating income more than doubled to $10.5 million from $4.3 million in 2024 ● Net income of $23.7 million ( $8.65 per diluted share), including a net positive impact of $11.5 million related to the release of our deferred tax valuation allowance ● Adjusted EBITDA of $26.7 million, compared to $22.3 million in 2024”
NCS Multistage Holdings, Inc. reported the quarter ended December 31, 2025 results: revenue $50.6 million, net income $15.0 million, EPS $5.34 per diluted share.
“Total revenues of $50.6 million, a 13% year-over-year improvement and exceeding the high end of prior guidance ● Operating income of $5.2 million increased 78% year-over-year, outpacing revenue growth ● Net income of $15.0 million ( $5.34 per diluted share), including a net positive impact of $9.8 million related to the release of our deferred tax valuation allowance ● Adjusted EBITDA of $9.2 million, compared to $8.2 million in the fourth quarter of 2024 and exceeding the high end of prior guidance”
National Vision Holdings, Inc. updated its fiscal 2026 guidance (initiated).
“National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ended January 3, 2026, and is providing its outlook for fiscal 2026.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.